moxifloxacin has been researched along with s20098 in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (s20098) | Trials (s20098) | Recent Studies (post-2010) (s20098) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 624 | 87 | 422 |
| Protein | Taxonomy | moxifloxacin (IC50) | s20098 (IC50) |
|---|---|---|---|
| Melatonin receptor type 1A | Homo sapiens (human) | 0.0001 | |
| Melatonin receptor type 1B | Homo sapiens (human) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caillaud, MA; Donazzolo, Y; Latreille, M; Mocaer, E; Seguin, L | 1 |
1 trial(s) available for moxifloxacin and s20098
| Article | Year |
|---|---|
Evaluation of the effects of therapeutic and supratherapeutic doses of agomelatine on the QT/QTc interval: a phase I, randomized, double-blind, placebo-controlled and positive-controlled, crossover thorough QT/QTc study conducted in healthy volunteers.
Topics: Acetamides; Adolescent; Adult; Antidepressive Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Moxifloxacin; Young Adult | 2014 |